{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:08:03Z","timestamp":1777464483698,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ygyno.2014.02.002","type":"journal-article","created":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T13:45:32Z","timestamp":1391694332000},"page":"593-598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Expression of DNA repair proteins in endometrial cancer predicts disease outcome"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5224-7406","authenticated-orcid":false,"given":"Paulette","family":"Mhawech-Fauceglia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Sharifian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiwie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne G.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Pejovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2014.02.002_bb0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/IGC.0b013e3181995f90","article-title":"Endometrial cancer state of the science meeting","volume":"19","author":"Kitchener","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11912-008-0076-x","article-title":"Uterine papillary serous carcinoma: state of the state","volume":"10","author":"Naumann","year":"2008","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0025","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/IGC.0b013e3181b7a1d5","article-title":"Pure papillary serous tumors of the endometrium: a clinic-pathological analysis of 61 cases from a single institution","volume":"19","author":"Benito","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/107327480901600102","article-title":"The molecular biology of endometrial cancers and the implications for pathogenesis, classification and targeted therapies","volume":"16","author":"Bansal","year":"2009","journal-title":"Cancer Control"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0035","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02664933","article-title":"Molecular alterations in the pathogenesis of endometrial adenocarcinoma. Therapeutic implications","volume":"8","author":"Cerezo","year":"2006","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0040","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1126\/science.1056154","article-title":"Human DNA repair genes","volume":"291","author":"Wood","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1383-5742(02)00009-1","article-title":"DNA repair\/pro-apoptotic dual-role proteins in five major DNA repair pathways; fail\u2013safe protection against carcinogenesis","volume":"511","author":"Bernstein","year":"2002","journal-title":"Mutat Res"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0050","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ctrv.2005.09.006","article-title":"The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer","volume":"31","author":"Madhusudan","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0055","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/1078-0432.CCR-07-2238","article-title":"Platinum resistance: the role of DNA repair pathways","volume":"14","author":"Martin","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1098-2280(1999)33:1<3::AID-EM2>3.0.CO;2-L","article-title":"Human DNA repair systems: an overview","volume":"33","author":"Yu","year":"1999","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0065","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.mam.2013.01.006","article-title":"Therapeutic applications of PARP inhibitors: anticancer therapy and beyond","author":"Curtin","year":"2013","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0070","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1517\/13543784.2012.707189","article-title":"Olaparib, PARP1 inhibitor in ovarian cancer","volume":"21","author":"Marchetti","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0075","series-title":"WHO classification","first-page":"217","article-title":"Tumors of the uterine corpus","author":"Silverberg","year":"2003"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0080","first-page":"125","article-title":"FIGO announcements, stages-1988 revision","volume":"35","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0085","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/modpathol.3800240","article-title":"Down-regulation of 14-3-3\u03c3 in ovary, prostate, and endometrial carcinomas is associated with CpG-methylation","volume":"18","author":"Mhawech","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0090","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1464-410X.2007.07090.x","article-title":"Predicting outcome in minimally invasive (T1A and T1B) urothelial bladder carcinoma using a panel of biomarkers: a high throughput tissue microarray analysis","volume":"100","author":"Mhawech-Fauceglia","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0095","first-page":"49767","article-title":"Integrated genomic characterization of endometrial carcinoma","author":"The Cancer genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ygyno.2014.02.002_bb0100","first-page":"53","article-title":"PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors","volume":"13","author":"Dedes","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/PGP.0b013e3181fa5a64","article-title":"Expression of poly (adenosine diphosphate-ribose) polymerase and p53 in epithelial ovarian cancer and their role in prognosis and disease outcome","volume":"30","author":"Godoy","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0110","doi-asserted-by":"crossref","first-page":"e30042","DOI":"10.1371\/journal.pone.0030042","article-title":"BRCAness profile of sporadic ovarian cancer predicts disease recurrence","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0115","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.ejca.2010.11.029","article-title":"Expression of DNA repair genes in ovarian cancer samples: biological and clinical considerations","volume":"47","author":"Ganzinelli","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ijc.11731","article-title":"Poly(ADP-ribose) polymerase-1, a novel partner of progesterone receptors in endometrial cancer and its precursors","volume":"109","author":"Ghabreau","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0125","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1200\/JCO.2009.26.9589","article-title":"Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval","volume":"28","author":"Fong","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(10)60892-6","article-title":"Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial","volume":"376","author":"Tutt","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0135","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/IGC.0b013e3182798188","article-title":"BRCA1 immunohistochemical staining as a prognostic indicator in uterine serous carcinoma","volume":"23","author":"Beirne","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0145","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ygyno.2010.11.037","article-title":"Expression of \u03b3-H2AX in endometrial carcinomas: an immunohistochemical study with p53","volume":"121","author":"Brunner","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0150","first-page":"275","article-title":"P53 overexpression as a prognostic indicator in endometrial carcinoma","volume":"24","author":"Ozalp","year":"2003","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ygyno.2014.02.002_bb0155","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004347-200404000-00007","article-title":"Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level","volume":"23","author":"Alkushi","year":"2004","journal-title":"Int J Gynecol Pathol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814001206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814001206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:37:15Z","timestamp":1716511035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814001206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0090825814001206"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.02.002","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of DNA repair proteins in endometrial cancer predicts disease outcome","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}